Ischemic Stroke News and Research

RSS

Landmark study heralds new era in stroke treatment worldwide

A landmark study published in the New England Journal of Medicine today heralds a new era in stroke treatment across the globe.

12 Feb 2015

Studies show neurointerventional surgery reduces stroke mortality rate by 50%

Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.

12 Feb 2015

Retigabine drug could reduce debilitating impact of strokes

New research suggests that an already-approved drug could dramatically reduce the debilitating impact of strokes, which affect nearly a million Americans every year.

5 Feb 2015

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair of Retinal Degeneration Research, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered gene interactions that determine whether cells live or die in such conditions as age-related macular degeneration and ischemic stroke.

31 Jan 2015

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, according to a review published in this month's Mayo Clinic Proceedings. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration panel convened last fall.

28 Jan 2015

Male stroke patients who live alone are at greater risk of premature death

Men who live alone have a considerably greater long-term risk of dying prematurely than other patients. This is shown in a doctoral thesis that followed 1,090 stroke cases in western Sweden.

21 Jan 2015

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).

8 Jan 2015

Study: Placental cells may possibly treat damaged nerves

New findings suggest that placental cells may potentially treat damaged nerves possibly leading the way to new treatment for stroke patients.

5 Jan 2015

Novastem uses Stemedica's stem cell products to treat patient in ischemic stroke study

Novastem, a leader in regenerative medicine, announces the treatment of its first patient in its study for ischemic stroke at Clinica Santa Clarita.

25 Dec 2014

Treatment for stroke: Intra-arterial treatment more effective than standard medical care for clot removal

Study results released today in The New England Journal of Medicine gave the world of stroke care more evidence that physicians are winning the battle against this debilitating disease, which affects as many as one in six people.

23 Dec 2014

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that intra-arterial stroke treatment, including the company's clot extraction technology, was shown to be significantly more effective than medical management with tissue plasminogen activator (tPA), which is the current standard of care.

18 Dec 2014

Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has launched a new formulation of LIXIANA 60 mg Tablets (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban, approval to market: September 26, 2014; NHI drug price listing: November 25, 2014) in Japan for the recently approved indications: the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and pulmonary thromboembolism (PE)].

8 Dec 2014

Researchers uncover easily detectable, 'pre-malignant' state in the blood

Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and Harvard-affiliated hospitals have uncovered an easily detectable, "pre-malignant" state in the blood that significantly increases the likelihood that an individual will go on to develop blood cancers such as leukemia, lymphoma, or myelodysplastic syndrome.

27 Nov 2014

Hospital bed positioning can affect outcomes of stroke patients

During the first 24 hours after a stroke, attention to detail --such as hospital bed positioning -- is critical to patient outcomes.

31 Oct 2014

FDA recommens approval of Daiichi Sankyo's once-daily SAVAYSA for patients with NVAF

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee voted 9 to 1 to recommend approval of once-daily SAVAYSA (edoxaban) 60 mg dosing regimen for the reduction in risk of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (NVAF).

30 Oct 2014

UCLA earns Get With The Guidelines-Stroke Gold-Plus Quality Achievement Award

he UCLA Comprehensive Stroke Center at Ronald Reagan UCLA Medical Center has received the Get With The Guidelines-Stroke Gold-Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American Stroke Association for the treatment of stroke patients.

28 Oct 2014

Ischemic Stroke News and Research

Landmark study heralds new era in stroke treatment worldwide

Studies show neurointerventional surgery reduces stroke mortality rate by 50%

Retigabine drug could reduce debilitating impact of strokes

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Male stroke patients who live alone are at greater risk of premature death

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Study: Placental cells may possibly treat damaged nerves

Novastem uses Stemedica's stem cell products to treat patient in ischemic stroke study

Treatment for stroke: Intra-arterial treatment more effective than standard medical care for clot removal

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Daiichi Sankyo releases new formulation of LIXIANA 60 mg Tablets

Researchers uncover easily detectable, 'pre-malignant' state in the blood

Hospital bed positioning can affect outcomes of stroke patients

FDA recommens approval of Daiichi Sankyo's once-daily SAVAYSA for patients with NVAF

UCLA earns Get With The Guidelines-Stroke Gold-Plus Quality Achievement Award

Monash University research explores long-term costs for two main causes of stroke

New research reveals innovative way to classify severity of stroke

Clot-buster shows promise in treating less severe forms of traumatic brain injury

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News